RIM
LGND icon

Ranger Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Ranger Investment Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.5M Sell
267,943
-2,040
-0.8% -$404K 3.87% 1
2025
Q4 		$51M Sell
269,983
-5,357
-2% -$1.03M 3.5% 2
2025
Q3 		$48.8M Sell
275,340
-24,685
-8% -$3.67M 3.4% 2
2025
Q2 		$34.1M Buy
300,025
+109,935
+58% +$11.8M 2.38% 9
2025
Q1 		$20M Buy
190,090
+107,885
+131% +$12.2M 1.43% 31
2024
Q4 		$8.81M Sell
82,205
-1,760
-2% -$199K 0.56% 53
2024
Q3 		$8.4M Buy
83,965
+15,570
+23% +$1.57M 0.54% 54
2024
Q2 		$5.76M Buy
68,395
+16,945
+33% +$1.35M 0.39% 62
2024
Q1 		$3.76M Buy
+51,450
New +$3.79M 0.24% 70

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Ranger Investment Management's LGND Position: Q1 2026 in Review

Ranger Investment Management reduced its Ligand Pharmaceuticals (LGND) stake by 0.76% in Q1 2026, selling an estimated $404K and leaving 267,943 shares worth $53.5M. The position accounts for 3.87% of the portfolio, ranked #1.

Ranger Investment Management first reported a position in LGND in Q1 2024 and has held it in 9 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Ranger Investment Management held 267,943 shares of Ligand Pharmaceuticals worth $53.5M as of Q1 2026.
  • Ranger Investment Management sold 2,040 Ligand Pharmaceuticals shares in Q1 2026, an estimated $404K.
  • Ligand Pharmaceuticals made up 3.87% of Ranger Investment Management's portfolio in Q1 2026, its #1 holding.
  • Ranger Investment Management first reported a position in Ligand Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Ranger Investment Management's 13F filing for Q1 2026, filed 15 May 2026.